Key financial indicators for Eli Lilly provide further context for market participants. The company commands a substantial market capitalization, noted at 68.38KCr, highlighting its significant scale within the industry. The Price-to-Earnings (P/E) ratio stands at 58.74, a figure often scrutinized by analysts to assess valuation. Furthermore, Eli Lilly offers a dividend yield of 0.83%.